MAY 08, 2018 9:01 PM PDT

Pure Form of An Illegal Euphoric Drug Treats PTSD

WRITTEN BY: Nouran Amin

 

Post-traumatic stress disorder (PTSD) is a psychiatric disorder where an individual has a difficult time recovering from a traumatic incident often caused by re-occurring memories of the situation leading to mental distress. According to the National co-morbidity published by Harvard Medical School, about 7% of people in the United States will suffer from PTSD during their lifetimes. Although many patients improve with therapy, anti-depressant medications and time, some will continue to have nightmares or flashbacks that persistently allow them to re-live a traumatic event. These patients will often experience severe symptoms that range from triggered anxiety attacks to depression, sleep disturbances, and dramatic changes in mood and behavior.

 

Now, an illegal euphoric drug may seek to treat individuals suffering from PTSD. The pure chemical form or active ingredient of this particular drug is MDMA (3,4-methylenedioxymethamphetamine). MDMA is known to alter mood and perception by targeting brain cells to release the neurohormone serotonin which is a brain chemical that regulates mood, aggression, sexual activity, sleep patterns and pain sensitivity. MDMA is also chemically the same as stimulants and hallucinogens.

Mental health investigators were curious if the chemical proteins of MDMA could be therapeutic for a multitude of metal health disorders. Dr. Michael Mithoefer, M.D., a psychiatrist who studies MDMA-assisted psychotherapy, described MDMA as "unique among drugs that decrease anxiety in that it isn’t sedating and doesn’t impair memory."

"People have clear recall of trauma without being overwhelmed by emotions or dissociating and being emotionally numb," he continues. "Our model is that MDMA is acting as a catalyst to the psychotherapeutic process, not as a stand-along drug."

MDMA was approved by the FDA for classic studies in treating chronic PTSD, but only under certain conditions. Regardless, it was seen that MDMA is the effective choice. “PTSD involves prominent fear responses and the fact that MDMA decreases fear by decreasing activity in the amygdala and increasing activity in prefrontal cortex," explains Mithoefer.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 11, 2020
Immunology
Could a Drug for Cats Treat COVID?
SEP 11, 2020
Could a Drug for Cats Treat COVID?
Canadian researchers have discovered that a drug used to treat coronavirus infections in cats shows promise in helping C ...
SEP 21, 2020
Microbiology
A Fast, Cheap Way to See if Two Antibiotics Work Together
SEP 21, 2020
A Fast, Cheap Way to See if Two Antibiotics Work Together
When a person has a bacterial infection, doctors can prescribe antibiotics. Some antibiotics combos can work better than ...
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
OCT 15, 2020
Cannabis Sciences
Can Cannabis Treat Traumatic Brain Injury?
OCT 15, 2020
Can Cannabis Treat Traumatic Brain Injury?
Traumatic brain injury (TBI) happens when the head is violently hit by an object or when an object pierces the skull and ...
OCT 11, 2020
Drug Discovery & Development
Treating Connective Tissue Disorders
OCT 11, 2020
Treating Connective Tissue Disorders
Collaborative research efforts are geared to improving disease that affects connective tissues via innovative drug deliv ...
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
Loading Comments...